within Pharmacolibrary.Drugs.A_AlimentaryTractAndMetabolism.A10B_BloodGlucoseLoweringDrugsExclInsulins.A10BX15_Imeglimin;

model Imeglimin
  extends Pharmacolibrary.Drugs.ATC.A.A10BX15;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>A10BX15</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Imeglimin is an oral hypoglycemic agent used for the treatment of type 2 diabetes mellitus. It is a first-in-class tetrahydrotriazine compound that improves glucose-dependent insulin secretion and enhances mitochondrial function. Imeglimin is approved for use in Japan and is under investigation or regulatory review in other regions.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters observed in healthy adult male and female volunteers after oral administration of imeglimin.</p><h4>References</h4><ol><li><p>Chevalier, C, et al., &amp; Fouqueray, P (2021). Pharmacokinetics of Imeglimin in Subjects with Moderate Hepatic Impairment. <i>Clinical pharmacokinetics</i> 60(4) 485–490. DOI:<a href=\"https://doi.org/10.1007/s40262-020-00948-1\">10.1007/s40262-020-00948-1</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33169345/\">https://pubmed.ncbi.nlm.nih.gov/33169345</a></p></li><li><p>Clémence, C, et al., &amp; Sébastien, B (2020). In Vitro Investigation, Pharmacokinetics, and Disposition of Imeglimin, a Novel Oral Antidiabetic Drug, in Preclinical Species and Humans. <i>Drug metabolism and disposition: the biological fate of chemicals</i> 48(12) 1330–1346. DOI:<a href=\"https://doi.org/10.1124/dmd.120.000154\">10.1124/dmd.120.000154</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33020063/\">https://pubmed.ncbi.nlm.nih.gov/33020063</a></p></li><li><p>Fouqueray, P, et al., &amp; Bolze, S (2022). Pharmacokinetics of Imeglimin in Caucasian and Japanese Healthy Subjects. <i>Clinical drug investigation</i> 42(9) 721–732. DOI:<a href=\"https://doi.org/10.1007/s40261-022-01181-3\">10.1007/s40261-022-01181-3</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/35867199/\">https://pubmed.ncbi.nlm.nih.gov/35867199</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Imeglimin;
